title: The in vitro secretion of acetylcholinesterase by adult stages of Heligmosomoides polygyrus: the effects of broad-spectrum anthelmintics.
abstract: The secretion of acetylcholinesterase (AChE) by female and male Heligmosomoides polygyrus was studied in different in vitro culture media. AChE secretion was increased in the presence of fetal calf serum or bovine serum albumin (BSA). In the absence of crowding effects, specific AChE activity in excretion/secretion products was higher for male (2.41 +/- 0.07 mumol min-1 l-1 mg-1) than for female (0.56 +/- 0.04 mumol min-1 mg-1) worms but on a per nematode basis both sexes showed comparable rates of secretion. Acetylthiocholine iodide was the favoured substrate of the enzyme. When the nematodes were incubated in vitro with albendazole (ABZ), ricobendazole (RBZ), mebendazole (MBZ), levamisole (LVM), morantel (MRT) or ivermectin (IVM), at concentrations from 1 mM to 10 nM, in RPMI medium for 2 or 6 h and then transferred to a drug-free medium (RPMI medium supplemented with 0.5% BSA) for 24 h or continuously exposed to the drugs in supplement-free medium (24 h), the concentration- and time-dependent inhibitory effects on AChE secretion were observed. The continued exposure to the drugs for all incubation periods (with a single exception for LVM 1 mM) produced the highest levels of inhibition. Under these conditions, the concentrations inhibiting the secretion of AChE by 50% (IC50) relative to drug-free controls were estimated. The IC50 values ranged from 0.012 microM (IVM) to 2.96 microM (MRT). The potential of this bioassay for the selective primary evaluation of new compounds with broad-spectrum anti-nematodal activity is discussed.
authors.affiliation: Department of Parasitology, Faculty of Pharmacy, Complutense University of Madrid, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Alonso-Villalobos
authors.forename: M M
authors.initials: MM
authors.lastname: Martinez-Grueiro
mesh_terms: D000110:Acetylcholinesterase / Q000032:analysis / Q000378:metabolism*; D015766:Albendazole / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology*; D003124:Colorimetry; D003470:Culture Media; D004353:Drug Evaluation, Preclinical / Q000662:veterinary*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D007559:Ivermectin / Q000494:pharmacology; D007978:Levamisole / Q000494:pharmacology; D008297:Male; D008463:Mebendazole / Q000494:pharmacology; D051379:Mice; D009015:Morantel / Q000494:pharmacology; D009351:Nematospiroides dubius / Q000187:drug effects* / Q000201:enzymology / Q000502:physiology; D012710:Serum Albumin, Bovine / Q000737:chemistry; D017206:Strongylida Infections / Q000188:drug therapy / Q000201:enzymology / Q000469:parasitology
chemical_list: D000871:Anthelmintics; D003470:Culture Media; D012710:Serum Albumin, Bovine; D007978:Levamisole; D007559:Ivermectin; D009015:Morantel; D008463:Mebendazole; D000110:Acetylcholinesterase; D015766:Albendazole; C027186:albendazole sulfoxide